| (Values in U.S. Thousands) | Dec, 2018 | Dec, 2017 | Dec, 2016 | Dec, 2015 | Dec, 2014 |
| Sales | 160,570 | 230,980 | 190,930 | 173,610 | 71,930 |
| Sales Growth | -30.48% | +20.98% | +9.98% | +141.36% | +202.74% |
| Net Income | -509,340 | -117,020 | -186,610 | -84,490 | -81,820 |
| Net Income Growth | -335.26% | +37.29% | -120.87% | -3.26% | -109.90% |
Intrexon Corp (XON)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.65 -0.20 (-4.12%) 01/31/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.65 unch (unch) -
for Fri, Jan 31st, 2020
Intrexon Corporation is a biotechnology company. It provides synthetic biology services. The Company designs and produces modular DNA control systems and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery. Intrexon Corporation is based in Germantown, Maryland.